Prior Positive Results Confirmed in MAPS-Sponsored, Philanthropy-Funded Phase 3 Trial
The world's most advanced psychedelic-assisted therapy trial has confirmed positive findings in the second Phase 3 trial of MDMA-assisted therapy for PTSD.
All News
Jury Finds in Favor of Plaintiffs in Trial on Harm Reduction and Medical Responsibility
On November 30, 2022, the jury in CARLA GATLIN, et al. vs DO LAB INC, et al. found in favor of the plaintiffs on the issues of medical responsibility and damages related to the death of a 20-year old woman …
A Psychedelic Caucus is Coming to Congress
November 17, 2022 MAPS celebrates the formation of the Congressional Psychedelics Advancing Clinical Treatments (PACT) Caucus, announced today. Led by Representatives Lou Correa (D-CA) and Jack Bergman …
Second MAPS-Sponsored Phase 3 Trial of MDMA-Assisted Therapy for PTSD Completed
FOR IMMEDIATE RELEASE: November 17, 2022 MAPS Public Benefit Corporation (MAPS PBC) has announced that the final participant in the second Phase 3 trial of psychedelic-assisted therapy, A Multi-Site Phase …
MAPS Analysis of Colorado’s Natural Medicine Health Act: Reviewing Proposition 122/Measure 58
MAPS’ Policy Values Over the last three years since MAPS published our Considerations For the Regulation and Decriminalization of Psychedelic Substances statement, multiple policy approaches to psychedelics …
Statement: Biden Administration Plans to Pardon Prior Federal Offenses of Simple Marijuana Possession
Today, the White House released a statement that President Joe Biden “will grant a pardon to all people convicted of simple marijuana possession under federal law” and “urged governors to take similar …
Following Landmark Achievement, California Psychedelic Decriminalization Bill Slated for 2023 Reintroduction
Senate Bill 519 would have decriminalized the personal possession of certain psychedelic substances, legalized life-saving public health interventions, and studied future approaches to increasing use of …
MAPS, in Coordination with Allies, Assists U.S. Sentencing Commission in Reaching Quorum
United States Sentencing Commission, which establishes and advises Congress on federal sentencing guidelines, reaches first quorum in 3 years and a full slate for first time since 2014 Delayed appointments …
Statement: Biden Administration Preparing for Potential FDA Approval of MDMA-Assisted Therapy for PTSD
Yesterday, a letter from the U.S. Department of Health and Human Services was made public describing the Food and Drug Administration’s “anticipated approval…within approximately 24 months” of …
MAPS Launches Psychedelic Fundamentals, an Online Education Curriculum From Leading Psychedelic Organization
Psychedelic Fundamentals is the initial offering in the new MAPS Digital Learning program introducing learners to the most important aspects of psychedelic history, research, uses, and harm reduction The …
MAPS Raises Nearly $1.6 Million in Christie’s NFT Auction
Historic Curated “Cartography of the Mind: A Curated NFT Sale” Auction is the First Time MAPS has Raised Money Using NFTs Beeple’s PILGRIMAGEPrice Realized: $252,000 Digital art, inspired by personal …
MDMA-Assisted Group Therapy for PTSD Among Veterans Study Will Proceed Following Successful Safety Negotiations
The FDA lifted the clinical hold from a MAPS-sponsored Phase 2 study of MDMA-assisted group therapy for the treatment of posttraumatic stress disorder among veterans at the VA Portland Health Care System …